Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | FGF23 | Q9GZV9 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL29266735 | 0.79 | ALDH1A1 (0.57) | ALDH1A1LMNATSHRHDAC8MEN1 | |
| SCHEMBL29405187 | 0.79 | ALDH1A1 (0.63) | ALDH1A1LMNATSHRHSD17B10HDAC8 | |
| SCHEMBL473080 | 0.79 | ALDH1A1 (0.63) | ALDH1A1LMNATSHRHSD17B10HDAC8 | |
| SCHEMBL7638 | 0.79 | ALDH1A1 (0.63) | ALDH1A1LMNATSHRHSD17B10HDAC8 | |
| Methyl Alcohol SCHEMBL28639807 | 0.76 | ALDH1A1 (0.55) | ALDH1A1MAPTLMNATSHRMAPK1 | |
| Propene SCHEMBL7948571 | 0.76 | ALDH1A1 (0.55) | ALDH1A1LMNATSHRHDAC8MEN1 | |
| SCHEMBL14229986 | 0.76 | ALDH1A1 (0.44) | ALDH1A1LMNATSHRMAPK1MAOB | |
| SCHEMBL26622733 | 0.76 | ALDH1A1 (0.44) | ALDH1A1LMNAKDM4ETSHRMAPK1 | |
| SCHEMBL15133699 | 0.76 | RAB9A (0.38) | ALDH1A1RAB9ASMN1; SMN2GAAMAPT | |
| SCHEMBL9328343 | 0.76 | HPGD (0.52) | ALDH1A1RAB9AMAPTLMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12038650-B2 | Multilayer phase difference plate, polarizing plate, and image display device | ZEON CORPORATION (JP) | 2024-07-16 | — | — | US | disclosed |
| US-11793063-B2 | Condensed-cyclic compound and organic light emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| US-11708358-B2 | Fungicidal oxadiazoles | FMC CORPORATION (US) | 2023-07-25 | — | — | US | disclosed |
| US-11647668-B2 | Organometallic compound and organic light-emitting device including the same | Samsung Display Co., Lid. (KR) | 2023-05-09 | — | — | US | disclosed |
| US-20230016922-A1 | VISIBLE-LIGHT MEDIATED ORGANOPHOTOREDOX CATALYTIC DEUTERATION OF AROMATIC AND ALIPHATIC ALDEHYDES | NATIONAL INSTITUTES OF HEALTH | 2023-01-19 | — | — | US | disclosed |
| US-20220177419-A1 | MULTILAYER PHASE DIFFERENCE PLATE, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | ZEON CORPORATION (JP) | 2022-06-09 | — | — | US | disclosed |
| EP-3901156-A1 | NITROOXYDERIVATIVE OF ROCK KINASE INHIBITOR | Vivavision (Shanghai) Ltd (CN) | 2021-10-27 | — | — | EP | disclosed |
| US-11072634-B2 | Inhibitors of transglutaminases | ZEDIRA GMBH (DE) | 2021-07-27 | — | — | US | disclosed |
| US-10935835-B2 | Optically anisotropic laminate, polarizing plate, and image display device | ZEON CORPORATION (JP) | 2021-03-02 | — | — | US | disclosed |
| EP-3783007-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2021-02-24 | — | — | EP | disclosed |
| US-20170349539-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC SUBSTANCE | ZEON CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
| US-20170335193-A1 | POLYMERIZABLE COMPOUND, MIXTURE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC PRODUCT, POLARIZING PLATE, FLAT PANEL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, AND ANTI-REFLECTION FILM | ZEON CORPORATION (JP) | 2017-11-23 | — | — | US | disclosed |
| US-9776954-B2 | Polymerizable compound, polymerizable composition, polymer, and optically anisotropic substance | ZEON CORPORATION (JP) | 2017-10-03 | — | — | US | disclosed |
| EP-2963068-B1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC BODY | ZEON CORP (JP) | 2017-08-23 | — | — | EP | disclosed |
| US-9695191-B2 | Conformationally constrained, fully synthetic macrocyclic compounds | POLYPHOR AG (CH) | 2017-07-04 | — | — | US | disclosed |
| US-9690022-B2 | Liquid crystal composition, phase difference plate, image display device, and method for controlling wavelength dispersion in optically anisotropic layer | ZEON CORPORATION (JP) | 2017-06-27 | — | — | US | disclosed |
| US-20170166815-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC PRODUCT | ZEON CORPORATION (JP) | 2017-06-15 | — | — | US | disclosed |
| US-20150285979-A1 | LIQUID CRYSTAL COMPOSITION, PHASE DIFFERENCE PLATE, IMAGE DISPLAY DEVICE, AND METHOD FOR CONTROLLING WAVELENGTH DISPERSION IN OPTICALLY ANISOTROPIC LAYER | ZEON CORPORATION (JP) | 2015-10-08 | — | — | US | disclosed |
| US-20130158044-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-06-20 | — | — | US | disclosed |
| WO-2012079956-A1 | ORGANIC LIGHT-EMITTING COMPONENT, AND USE OF A COPPER COMPLEX IN A CHARGE TRANSPORT LAYER | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2012-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793063-B2 | Condensed-cyclic compound and organic light emitting device including the same | CRY1, CRY2, CCNE2 | ALDH1A1 518/4885RAB9A 2481/4885SMN1; SMN2 4489/4885 |
| US-20130158044-A1 | PIPERAZINE-SUBSTITUTED BENZOTHIOPHENES FOR TREATMENT OF MENTAL DISORDERS | GRIN2C, TPH1, HTR2C | ALDH1A1 418/4885RAB9A 2915/4885SMN1; SMN2 1976/4885 |
| US-12038650-B2 | Multilayer phase difference plate, polarizing plate, and image display device | RAD1, RPAP1, RPA1 | ALDH1A1 4462/4885RAB9A 1715/4885SMN1; SMN2 1172/4885 |
| US-20220177419-A1 | MULTILAYER PHASE DIFFERENCE PLATE, POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | RAD1, RPAP1, RPA1 | ALDH1A1 4472/4885RAB9A 1704/4885SMN1; SMN2 1170/4885 |
| US-20170166815-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC PRODUCT | CCNA1, CCNA2, CCNO | ALDH1A1 1443/4885RAB9A 3691/4885SMN1; SMN2 2567/4885 |
| US-20230016922-A1 | VISIBLE-LIGHT MEDIATED ORGANOPHOTOREDOX CATALYTIC DEUTERATION OF AROMATIC AND ALIPHATIC ALDEHYDES | AOX1, TDO2, TALDO1 | ALDH1A1 34/4885RAB9A 4302/4885SMN1; SMN2 3267/4885 |
| US-11708358-B2 | Fungicidal oxadiazoles | OXA1L, NOX1, TH | ALDH1A1 603/4885RAB9A 2129/4885SMN1; SMN2 1193/4885 |
| US-20170349539-A1 | POLYMERIZABLE COMPOUND, POLYMERIZABLE COMPOSITION, POLYMER, AND OPTICALLY ANISOTROPIC SUBSTANCE | PYM1, CCNB2, CCNT1 | ALDH1A1 1453/4885RAB9A 4632/4885SMN1; SMN2 2539/4885 |
| US-11072634-B2 | Inhibitors of transglutaminases | TGM2, TGM3, TGM1 | ALDH1A1 1469/4885RAB9A 1872/4885SMN1; SMN2 3418/4885 |
| US-11647668-B2 | Organometallic compound and organic light-emitting device including the same | OCIAD1, LEF1, OXA1L | ALDH1A1 13/4885RAB9A 3166/4885SMN1; SMN2 4336/4885 |
| US-20170335193-A1 | POLYMERIZABLE COMPOUND, MIXTURE, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICAL FILM, OPTICALLY ANISOTROPIC PRODUCT, POLARIZING PLATE, FLAT PANEL DISPLAY DEVICE, ORGANIC ELECTROLUMINESCENCE DISPLAY DEVICE, AND ANTI-REFLECTION FILM | NR2E3, NR3C2, NR2C2 | ALDH1A1 3033/4885RAB9A 3745/4885SMN1; SMN2 3381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.